Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
ANIK
ANIK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest ANIK ETF News Today | Earnings, Events & Price Alerts
ANIK News
Healthcare Stocks Show Overbought Warning Signals
9h ago
Benzinga
Anika Therapeutics Q4 2025 Earnings Call Insights
6d ago
seekingalpha
Anika Therapeutics Releases Fiscal 2026 Guidance with Q4 Earnings Beat
6d ago
seekingalpha
Anika Therapeutics to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
Anika Therapeutics Faces Investor Lawsuit Over Securities Violations
Jan 26 2026
Globenewswire
Anika Therapeutics Shares Plunge 27% After Clinical Trial Fails to Meet Primary Endpoints
Jan 24 2026
Businesswire
Anika Therapeutics Shares Plunge 27.42% After Clinical Trial Results Fail to Meet Primary Endpoints
Dec 30 2025
Businesswire
Anika Therapeutics Faces Investigation After 27.42% Stock Drop Following Clinical Trial Results
Dec 30 2025
Newsfilter
Anika Therapeutics Faces Investigation After Hyalofast Trial Misses Key Endpoints
Dec 06 2025
Globenewswire
Anika Therapeutics Faces Investigation After 27.42% Stock Drop Due to Trial Results
Dec 06 2025
Newsfilter
Reminder for Anika Investors: Bragar Eagel & Squire, P.C. Urges Anika Therapeutics Shareholders to Reach Out About Ongoing Investigation
Oct 09 2025
Globenewswire
Biotech Stocks Recover in After-Hours Trading Driven by Positive Sector Trends
Oct 01 2025
NASDAQ.COM
ANIKA (ANIK) UPDATE: Bragar Eagel & Squire, P.C. Launches Investigation into Anika Therapeutics, Inc. for the Benefit of Stockholders and Urges Investors to Reach Out to the Firm
Sep 25 2025
Globenewswire
Arcturus Therapeutics (ARCT) Rises 8.7%: Could This Signal More Growth Ahead?
Sep 19 2025
NASDAQ.COM
Investor Notice: Pomerantz Law Firm Probes Allegations for Anika Therapeutics, Inc. Shareholders – ANIK
Sep 14 2025
Globenewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Sep 08 2025
PRnewswire
Show More News
